The TGA has published a web page outlining the Therapeutic Goods Advertising and Compliance Education Plan for 2024.

Please read today’s tech alert for more information on the plan, including relevant aspects of each education priority to listed medicines, such as High risk traditional medicines and the use of Nicotinamide adenine dinucleotide (NAD) in complementary medicines.